Delivery Order SPE2DB22D2206-SPE2DB24FKE63
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $38,700.68 to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a $58,180.33 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565964265 DUPIXENT 300 MG/2 ML PEN 2ML, a prescription pharmaceutical product, with an ultimate completion date of September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that AmerisourceBergen holds with the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $61,311.65 firm-fixed-price contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to support various federal healthcare programs and military treatment facilities through its extensive...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,354.70 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which does not have a set-aside designation, is for the supply of 4565768652 - DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The ultimate completion date for the contract is September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $14,216.79 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, with a period of performance through February 5, 2025. AmerisourceBergen, a for-profit organization, is the prime contractor and this award does not indicate any set-aside designation....
The U.S. Defense Logistics Agency (DLA) awarded a $23,118.45 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,964,631 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This delivery order is part of a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,260.96 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through May 29, 2024. This order was placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,542.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4564155597 DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of April 4, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,924.04 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $23,037.74 firm fixed-price contract is for the delivery of 4,565,405,274 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The ultimate completion date for this order is August 12, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery...